The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...